# Shandong Weigao Interventional Medical Technology

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/shandong-weigao-interventional-medical-technology

- Industry: Medical Devices & Equipment
- Headquarters: Weihai, China
- Total disclosed funding: $156M
- Latest round: Series A (Oct 26, 2021)
- Investors on record: 5

## About

Established in 2020 and based in Weihai, China, Shandong Weigao Interventional Medical Technology is a medical instruments company that focuses on research, development and production of consumables for vascular interventional devices. In October 2021, the company raised RMB 1 billion in series A funding from new investors.

The company's main business is research, development sales and production of medical instruments. The company's main products include drug-coated stents, bioabsorbable drug stents, intracranial electrolysis coils, intracranial thrombus removal stents, extracranial drainage kits, human intraluminal stents, vena cava filter system. The products use in the field of cardiovascular intervention, neurological intervention and peripheral vascular intervention.

## Funding rounds

- Series A, Oct 26, 2021, $156M — CCB International, Haitong-Fortis Private Equity Fund Management, China Renaissance, Xinjin Investment, Jiangxi Jimin Kexin Pharmaceutical Industry Investment

## Investors

- CCB International (https://capitalatlas.ai/funds/ccb-international) — Series A
- Haitong-Fortis Private Equity Fund Management (https://capitalatlas.ai/funds/haitong-fortis-private-equity-fund-management) — Series A
- China Renaissance (https://capitalatlas.ai/funds/china-renaissance) — Series A
- Xinjin Investment (https://capitalatlas.ai/funds/xinjin-investment) — Series A
- Jiangxi Jimin Kexin Pharmaceutical Industry Investment — Series A